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Summary
 
The expression of different sets of immunoglobulin specificities by fetal and adult B lympho-
cytes is a long-standing puzzle in immunology. Recently it has become clear that production of
immunoglobulin 
 
m
 
 heavy chain and subsequent assembly with a surrogate light chain to form
the pre-B cell receptor complex is critical for development of B cells. Here we show that in-
stead of promoting pre–B cell progression as in adult bone marrow, this complex inhibits pre–B
cell growth in fetal liver. Curiously, we identify a fetal-associated V
 
H
 
11 
 
m
 
 heavy chain that al-
lows continued pre-B proliferation in fetal liver. Interestingly, this heavy chain does not associ-
ate efficiently with a surrogate light chain, providing a previously unrecognized mechanism for
skewing the expression of distinctive V
 
H
 
 genes toward fetal through early neonatal life.
 
I
 
mmune responses during the neonatal period show sig-
nificant differences from those in the adult, with striking
deficiencies in the ability to respond to certain antigens (1,
2), although the mechanism for this shift is not yet com-
pletely understood. Consistent with their restricted ability
to respond to antigenic challenge, fetal and neonatal B cell
precursors use a restricted set of heavy chain V
 
H
 
 (Ig heavy
chain variable region) genes, preferentially from segments
proximal to the Ig diversity element (D), such as V
 
H
 
81X in
mice (3, 4). The expansion from a restricted set of genes
used by neonatal B cells to the wide variety employed in
the adult (3–5) is referred to as repertoire maturation. Al-
though the phenomenon has been appreciated for many
years, the molecular and cellular mechanisms that result in
this change are not yet understood. Since fetal B cells pref-
erentially express V
 
H
 
 segments proximal to D, ordered ac-
cessibility to recombination has been suggested as a pos-
sibility. Yet this cannot be the full explanation, since
preferential rearrangement of D-proximal V
 
H
 
 segments is also
observed in B precursor cells in adult bone marrow (6). In ad-
dition, productive rearrangements of such genes predominate
in fetal cells but become infrequent in adult precursors (7–9).
Furthermore, some V
 
H
 
 genes not proximal to D, such as
V
 
H
 
11, also show expression biased to B cells generated from
the fetal stage through the early neonatal stage (fetally/neona-
tally) (10, 11). These observations imply that mechanism(s) in
addition to rearrangement accessibility, possibly the differential
control of B cell development by particular V
 
H
 
 genes, shape
the distinctive repertoires of fetal and adult times.
Early B lineage development is critically dependent on
expression of Ig 
 
m
 
 heavy chain at the pre-B stage, where it
associates with a surrogate light chain (SLC), composed of
two molecules, 
 
l
 
5 and VpreB (12, 13), which collectively
form a complex known as the pre–B cell receptor (BCR).
The importance of the pre-BCR in this process is illus-
trated by the developmental arrest induced upon elimina-
tion of any of these components in gene-targeted mice
(14–16). Successful pre-BCR assembly induces several hall-
mark events associated with progression from the pro-B to
large pre-B stage in the bone marrow (17), including
downregulated expression of genes involved in Ig rear-
rangement, such as terminal deoxynucleotidyl transferase
(TdT) (18, 19) and the recombinase-activating genes
(Rag), Rag-1 and Rag-2 (20, 21). These changes coincide
with a sharp proliferative expansion in bone marrow, which
interestingly occurs at precisely the stage where representa-
tion of the fetally biased V
 
H
 
81X shows a profound decrease
(7). This alteration of V
 
H
 
 representation at the stage of
 
m
 
-dependent proliferation suggests to us that differences in
the V region of the 
 
m
 
 heavy chain itself may critically influ-
ence the growth of B cell precursors during fetal and adult
development.
By establishing V
 
H
 
11 transgenic (Tg) mouse lines ex-
pressing two different levels of 
 
m
 
 heavy chain, in compari-
son with other V
 
H
 
 
 
m
 
 Tg lines, we demonstrate in this paper
a distinctive in vitro proliferative response by fetal pre–B
cells to pre-BCR assembly, with clear in vivo consequences
on subsequent B cell development. We propose that this
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differential response by fetal pre–B cells to SLC-
 
m
 
 provides
a previously unrecognized mechanism for skewing the ex-
pression of distinctive V
 
H
 
 genes toward fetal/neonatal life.
 
Materials and Methods
 
Tg Mice.
 
A functionally rearranged V
 
H
 
11 gene was cloned
from a CD5
 
1
 
 B cell–derived hybridoma cell line (2-2G4) secret-
ing an IgM antibody reacting with bromelain-treated mouse red
blood cells (10). The rearranged gene, known to reside on a 4.8-kb
EcoRI/EcoRI fragment, was ligated into 
 
l
 
 phage arms and used
for generating a library. Positive clones were identified on colony
lifts by hybridization with pJ11, and the 
 
l
 
 phage was converted
into a phagemid vector. The EcoRI 4.8-kb fragment was gel pu-
rified, modified by trimming the 3
 
9
 
 end with XhoI, and then li-
gated into the pICEM19H C
 
m
 
 plasmid vector. Appropriate V
 
H
 
orientation was established by mapping several clones with appro-
priate restriction enzymes. The 17-kb V
 
H
 
11-C
 
m
 
 construct was
gel isolated and used for microinjection. Litters so generated were
screened by PCR amplification for rearranged V
 
H
 
11-J
 
H
 
1 (Ig
heavy chain joining segment) using DNA made from tail frag-
ments. Tg
 
1
 
 founders were mated to C.B-17Icr, allowing discrim-
ination of the transgene C
 
m
 
 allotype (Igh
 
a
 
) from the endogenous
C
 
m
 
 (Igh
 
b
 
). Two lines, high copy BR1 and low copy BR5, were
backcrossed more than six times to C.B-17 and used for analyses.
Human (Hu) 
 
m
 
 Tg mice originally generated by M. Nussenzweig
(22) and Rag-1
 
2
 
 mice generated by E. Spanapoulou and D. Bal-
timore (15) were provided by E. Spanopoulou (Mt. Sinai School
of Medicine, New York) and maintained in our animal facility.
3H9 Tg animals (23) were provided by M. Weigert (Princeton
University, Princeton, NJ).
 
Cell Staining and Culture.
 
Single cell suspensions of bone mar-
row (from 3-mo-old animals) or fetal liver (from animals at day 16
of gestation) were stained, analyzed, and sorted as previously de-
scribed (17, 18) with anti-CD45R(B220) (allophycocyanin-6B2),
anti-CD43 (fluorescein-S7), and anti-CD24/HSA (phycoerythrin-
30F1). Reanalysis of sorted fractions consistently showed purities
 
.
 
95%. The FLST2 stromal line–dependent proliferation assay was
performed as previously described (15, 17), except that cultures
were supplemented with 100 U/ml of recombinant human IL-7
(gift of S. Gillis, Immunex Corp., Seattle, WA). 2–5 
 
3
 
 10
 
4
 
 cells
(CD43
 
1
 
HSA
 
1
 
B220
 
1
 
) were sorted per 1 ml well. Cells were har-
vested after 4 d, stained as above, and analyzed by flow cytometry.
 
Immunoprecipitation Analysis.
 
Digitonin lysates prepared from
10
 
5
 
–10
 
6
 
 cells were immunoprecipitated with antibodies to 
 
m
 
 (M41),
 
l
 
5 (LM34-8E), VpreB (VP245), or 
 
k
 
 (187.1), and then proteins
were resolved by SDS-10% PAGE as previously described (19).
After electrotransfer to PVDF membranes (Dupont-NEN, Boston,
MA), filters were blocked with milk protein, probed with horse-
radish peroxidase–conjugated M41 rat anti–mouse 
 
m
 
 mAb, washed,
developed using Supersignal Substrate (Pierce, Rockford, IL), and
exposed to Reflection film (Dupont-NEN). In some experi-
ments, 
 
m
 
 immunoprecipitates were first deglycosylated by treat-
ment with anhydrous trifluoromethanesulfonic acid according to
the manufacturer’s protocol (“GlycoFree”; Oxford GlycoSystems,
Bedford, MA) before electrophoresis. Freshly isolated thymocytes
were stimulated for 5 min at 37
 
8
 
C with 0.1 mM pervanidate to
induce ubiquitination of TCR-
 
z
 
 (24). The TCR complex was
immunoprecipitated from lysates of treated or untreated thy-
mocytes using anti–TCR-
 
b
 
 mAb, resolved by SDS-11% PAGE,
and transferred to PVDF membrane. V
 
H
 
11-
 
m
 
 immunoprecipitate
was loaded in an adjacent lane. Filters were immunoblotted with
an antiubiquitin antibody (MAB1510; Chemicon International,
Temecula, CA).
 
Reverse Transcriptase PCR Analysis.
 
cDNA was prepared from
total RNA as previously described (18) and then amplified with
primers specific for 
 
b
 
-actin, TdT, Rag-1, and Rag-2. PCR, blot-
ting, and hybridization were performed as previously described (18).
 
Transfection Assays.
 
DNA constructs were introduced into the
ret 02/1 cell line by electroporation as previously described (19).
The SP6
 
m
 
 plasmid contains a 
 
neo
 
r
 
 
 
gene derived from pSV2-neo in
addition to the heavy chain gene (25). For transfections with
transgenic constructs (V
 
H
 
11, V
 
H
 
11/V
 
k
 
9, V
 
H
 
3H9 [23], and V
 
H
 
81X
[26]), cells were cotransfected with pSV2-neo to allow selection
with G418. A rearranged V
 
k
 
9J
 
k
 
2C
 
k
 
 light chain gene, present on
an 8.4-kb BamHI fragment, was cloned from the 2-2G4 hybrid-
oma (10). BamHI-digested DNA of this size was ligated into 
 
l
 
phage arms, the library was screened with nick-translated pECk
probe, and a positive clone was ligated into pBluescript II KS
(Stratagene, La Jolla, CA).
 
Results and Discussion
 
Transfection of 
 
m
 
 heavy chain into pro–B cell lines re-
sults in the downregulation of TdT expression (19), provid-
ing a model system for investigating the effect of different V
 
H
 
segments on pre-BCR assembly. Expression of several 
 
m
 
heavy chains with different V
 
H
 
 (V
 
H
 
DJ
 
H
 
) regions, such as Sp6
and 3H9, in the pro–B cell line ret02/1 results in dimin-
ished message levels of TdT as well as Rag-1 (Fig. 1). These
changes mimic those normally seen in the differentiation of
pro–B cells to the early pre–B cell stage in vivo (18–21).
However, not all 
 
m
 
 heavy chains are equally efficient in this
assay: transfectants with V
 
H
 
81X or V
 
H
 
11 
 
m
 
 chains do not
show significant TdT or Rag-1 downregulation when com-
pared to the parental line (Fig. 1). Since V
 
H
 
81X 
 
m
 
 chains
often do not associate well with 
 
l
 
5 (27), it was reasonable
to ask whether pre-BCR assembly was inefficient in V
 
H
 
11
transfectants.
To assess the extent of pre-BCR assembly with V
 
H
 
11 
 
m
 
,
we performed immunoprecipitation experiments. SDS-PAGE
analysis revealed that the V
 
H
 
11 
 
m
 
 protein expressed in trans-
fected cell lines exists as two forms, a predominant species
with an M
 
r
 
 20 kD greater than other 
 
m
 
 heavy chains tested,
and a minor species with near normal mobility (Fig. 2 
 
a
 
).
These 
 
m
 
 species exhibited different extents of association
with SLC: although the conventionally size 
 
m pairs with l5
Figure 1. Effect of m heavy chains with different V regions on down-
regulation of TdT and Rag-1 message levels as revealed by reverse tran-
scriptase PCR. RNA prepared from the ret02/1 cell line parent (2), from
a clone transfected with neo alone (neo), and from two clones each gener-
ated by transfection with the four different VH-m constructs indicated. b-actin
levels were used to compare efficiency of RNA/cDNA preparation.261 Wasserman et al. Brief Definitive Report
and VpreB, this is not true of the other species. Only about
half of the larger m species is complexed with l5, and even
less (z5%) is associated with VpreB (Fig. 2 a). Since both
l5 and VpreB are required for pre-BCR function, these
data demonstrate that almost none of the larger m protein is
assembled into complete pre-BCR complexes. Moreover,
because the larger m form makes up 80% of VH11-m, the
assembled pre-BCR is decreased by fivefold in these trans-
fectants.
Significantly, the aberrant molecular form of VH11-m
was not detected in cells cotransfected with Vk9 light chain
(Fig. 2 b), the light chain found frequently in mature VH111
B cells (10, 11). This suggests that the higher Mr m species
represents a posttranslationally modified form, possibly tar-
geted for degradation due to incomplete association with
SLC, since a light chain capable of assembling with VH11-m
eliminates the aberrant band. Deglycosylation of VH11-m
(Fig. 2 c, left) did not collapse the double band. Furthermore,
the aberrant species was not detected in an antiubiquitin
immunoblot (Fig. 2 c, right). The nature of modification re-
sponsible for the slowly migrating m species is still under
study, and failure to completely assemble with SLC does
not always generate it, since VH81X chains that failed to as-
sociate with l5 showed conventional size m (27). None-
theless, our data suggest that the downregulation of TdT
and Rag gene expression in m heavy chain transfectants
depends on efficient assembly of a complete pre-BCR and
therefore suggests that both VH81X-m and VH11-m are in-
efficient in mediating these changes.
To test whether normal nontransformed pre–B cells de-
veloping in vivo also show a comparable dependence on
particular VH m, we examined two lines of VH11 m trans-
genic mice representing low (BR5) and high (BR1) copy
number, comparing them with several other m transgenic
mouse lines. To eliminate any effect by endogenous m ex-
pression and to restrict our analysis to the pre–B cell stage,
we used Rag-12 mice bearing Ig Tgs. As Fig. 3 a shows, a
differential ability to downregulate Rag-2 in adult bone
marrow was clearly evident when comparing low copy
number BR5 m with 3H9 m Tg mice, in agreement with
data from the cell line transfection experiments. In addi-
tion, a human m Tg (Hu m), previously shown to promote
B cell development in mice (15, 22), also induced down-
regulated Rag-2 expression. Thus, the extent of bone mar-
row pre–B cell progression in Ig transgenic mice, as moni-
tored by changes in gene expression that we measured,
appears to be dependent on VH-mediated pre-BCR assem-
bly, with VH11 being particularly ineffective.
Unexpectedly, the high copy number BR1 VH11 m Tg
mice showed Rag-2 downregulation, different from the
transfection data (Fig. 3 a); however, analysis of the m pro-
tein in these two lines provides a potential explanation. Al-
though the novel and conventional m species are both gen-
erated in developing B lineage cells in these Tg mice, the
conventionally sized m predominates in pre-B cells from
the high copy number BR1 mouse, whereas BR5 pre–B
Figure 2. (a) SDS-PAGE analysis of pre-BCR components reveals in-
complete assembly of VH11-m with SLC. Cell lysates from nontransfected
(lane 1), VHSP6-m–transfected (lane 2), and VH11-m–transfected (lane 3)
ret02/1 cells were immunoprecipitated and then blotted as shown. Densi-
tometry indicates that the intensity of the upper to lower band in the
VH11-m–transfectant is 5:1 with anti-m, 0.1:1 with VpreB, and 2:1 with
anti–l5. Numbers on the left indicate the Mr of standards (in kD). (b)
Vk9 eliminates the slowly migrating VH11-m species. Immunoprecipita-
tion of VH11 and VH11/Vk9 transfectants with antibodies as indicated,
then blotted with anti-m. The left-most lane shows a short (1/4 time) ex-
posure for the VH11 transfectant anti-m immunoprecipitate. (c) Deglyco-
sylation (left panel) does not eliminate the aberrant VH11-m species. Con-
trol (2) and treated (1) m immunoprecipitates from VH11 and SP6
transfectants. Antiubiquitin immunoblotting (right panel) does not detect
VH11-m heavy chain. As a positive control, TCR-z ubiquitination was
induced by incubation of thymocytes with pervanidate (1 lane).
Figure 3. Analysis of gene expression and m chain protein in pre-B
cells. (a) RNA prepared from B2201CD431HSA1 cell fraction sorted
from bone marrow of Rag-12m Tg mice. All values expressed relative to
the maximum level seen with RNA from comparable fraction in Rag-12
mice (lane 2). (b) Pre-B cells (B2201CD431HSAhi; Fr. C9; reference 17)
sorted from BR1 and BR5 Rag-12 bone marrow and from BALB/c
bone marrow were immunoprecipitated and blotted with anti-m. The
relative intensities (with BALB/c set to 1) are 1.2, 1.5 (upper, lower) for
BR1 and 0.5, 0.1 for BR5.262 Pre–B Receptor Regulation of Fetal and Adult B Lymphopoiesis
cells showed predominance of the aberrant size m (Fig. 3 b),
similar to the transfectants. Importantly, while BR1 pre-B
cells express more total m protein than do pre-B cells from
non-Tg mice, the m levels in the BR5 line are closer to
those in wild-type mice. Thus, we consider that the BR5
line, which expresses physiological levels of m and fails to
promote Rag-2 downmodulation, provides a realistic pic-
ture of VH11 function in vivo. Moreover, the downregula-
tion of Rag-2 in the BR1 line likely reflects super-physio-
logic m expression that is presumably able to compensate
for the inefficient assembly of VH11 with SLC.
To further pursue how the efficiency of pre-BCR as-
sembly influences pre-B and subsequent B cell develop-
ment, we next tested the growth response of fetal and adult
pre–B cells to m expression in stromal cell culture (Fig. 4),
since a proliferative burst is another characteristic associated
with early pre–B cell progression in the bone marrow. As
Fig. 4 a shows, analysis of short term cultures of pre–B cells
sorted from bone marrow of competent (Hu m or BR1 m)
and incompetent (BR5 m) adult Tg mice (on a Rag-12
background) revealed that Tg expression had relatively lit-
tle effect on cell growth, with any enhancement in prolif-
eration largely balanced by differentiation and exit from
cell cycle. Strikingly, however, analysis of the comparable
pre-B fraction isolated from fetal liver of the same trans-
genic mouse lines revealed that Hu m or BR1 m expression
arrested cell growth. In contrast, the BR5 VH11 line
showed little inhibition of fetal liver B-lineage prolifera-
tion, and instead allowed continued pre–B cell growth.
Furthermore, consistent with in vitro analysis, the fre-
quency of pre–B cells in liver of newborn Rag-12 Tg mice
was significantly reduced (relative to nontransgenic mice)
in Tg animals with SLC-associating VH genes, such as Hu m,
but showed near normal levels in BR5 Tg mice (Fig. 4 b).
Importantly, when analyzed on a Rag-11 background, the
majority of BR5 B2201 B-lineage cells in spleen of neona-
tal (1 wk) BR5 mice were surface VH11 Tg1, without en-
dogenous m surface expression (Fig. 4 c). In contrast, VH11 m
did not promote efficient B cell development in adult BR5
mice, since B cells in these mice comprised predominantly
cells bearing exclusively endogenous m. As with the Rag-2
downregulation analysis, the BR1 line appeared normal,
showing decreased pre–B cell development early in ontog-
eny (Fig. 4 b) and predominance of Tg1 B cells in the adult
(Fig. 4 c), likely due to superphysiologic VH11 m levels. In
summary, cells in fetal liver expressing SLC-nonassociating
VH regions show a growth advantage compared to cells
with SLC-associating VH segments. In contrast, the reverse
is true in adult bone marrow where successful pre-BCR as-
sembly is important for B lineage progression.
Our analysis suggests that a bias in VH representation can
occur after successful VH-DJH rearrangement due to inter-
action (or lack thereof) with SLC, and this assembly-medi-
ated response differs between fetal and adult pre–B cells.
We suggest that skewed representation of B cells expressing
certain VH m, such as VH81X or VH11, generated during fe-
tal time can result from active inhibition of clonal expan-
sion of other B cells bearing SLC-associating m. This model
predicts a significant (and different) change in VDJ repre-
sentation at the late pre–B cell stage during both fetal and
adult B cell development. Most VH81X and VH11 produc-
tive heavy chain sequences reveal a fetal/neonatal origin
reflected by a low level of CDR3 diversity (28, 29), due to
low levels of TdT during the fetal stage, which results in
little addition of extra nucleotides at heavy chain V–D and
D–J junctions (18, 30). This has led some to suggest that
the representation of certain VH genes (such as VH81X and
VH11) is biased by a requirement for nucleotide homology
Figure 4. Different consequences of m heavy chain expression during fetal and adult B cell development. (a) Growth effect of various m transgenes
(Rag-12 background) after 4-d stromal cell–dependent cultures of B2201CD431HSA1 cells sorted from bone marrow and fetal liver. Live cell number
recovered after culture of Rag-12 bone marrow (average sixfold increase) is set to 1.0. (b) Frequency of pre-B cells in liver of newborn Rag-12 mice
bearing indicated m transgenes compared to nontransgenic mice (2) as determined by flow cytometry. (c) Flow cytometry analysis of B2201 cell in spleen
of BR5 and BR1 mice at 1 wk and 3 mo. Numbers show percentage of live cells in a lymphocyte size gate for indicated quadrants. Representative data
from three analyses.263 Wasserman et al. Brief Definitive Report
at the junctions (28, 31), such that TdT-mediated addition
in the adult would result in a preponderance of nonpro-
ductive joints. However, recent analysis of VH81X se-
quences generated from adult bone marrow pre–B cell cul-
tures has revealed considerable CDR3 diversity in
productive rearrangements (9), demonstrating that these can
occur in the presence of TdT. Thus, the difference in TdT
levels with ontogeny cannot account for the skewed reper-
toire difference.
As animals mature from the fetal to the adult stage, the
potential to generate a more diverse VH m repertoire in-
creases due to TdT expression. This increasing heterogene-
ity of Ig heavy chain, important for generating more diver-
sity in the adult, may require a more intricate mechanism
for selection of appropriate VH m, such as screening VH
structures for an ability to pair with light chains. If this is
the case, then SLC may provide a template for an “aver-
age” light chain structure. This process would be less im-
portant during fetal B lymphopoiesis where TdT is absent,
resulting in expression of a more restricted set of VH re-
gions. Thus a dependence of the pro-B to pre-B transition
on efficient pre-BCR assembly in adult mouse bone mar-
row could be viewed as an elaboration on a simpler mode
of B cell development represented in fetal liver.
Whether B cell development with these SLC-nonassoci-
ating VH genes is completely SLC-independent remains to
be determined, since SLC is expressed at the highest levels
on the surface of B lineage cells at a developmental stage
before heavy chain expression (32), where it could con-
ceivably provide a growth signal independent of m. Re-
gardless of a possible role for SLC in the pro–B receptor, it
appears that the pre-BCR phase of fetal B lymphopoiesis is
quite distinctive compared to that in adult bone marrow,
allowing selective expansion of cells with certain VH genes.
We speculate that over evolution, useful VH regions have
been selected into the germline repertoire and that the dis-
tinctive response of fetal pre–B cells to SLC association
provides a mechanism for their preferential expression. De-
termining why fetal B cells should express this primordial
repertoire remains an interesting subject for future studies.
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